Cargando…
The inflammatory cellular feature in the peripheral blood of chronic subdural hematoma patients
BACKGROUND: Chronic subdural hematoma (CSDH) is a common neurosurgical disease with an increasing incidence. The absorption route of CSDH is not clear. Whether inflammatory factors enter the peripheral blood and cause systemic reactions is unknown. METHODS: We screened 105 CSDH patients and 105 cont...
Autores principales: | Fan, Yibing, Wu, Di, Zhang, Xinjie, Jiang, Weiwei, Nie, Meng, Liu, Xuanhui, Xiang, Tangtang, Liu, Mingqi, Chen, Yupeng, Feng, Dongyi, Huang, Jinhao, Gao, Chuang, Jiang, Rongcai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551118/ https://www.ncbi.nlm.nih.gov/pubmed/36114782 http://dx.doi.org/10.1002/jcla.24706 |
Ejemplares similares
-
Possible mechanism and Atorvastatin-based treatment in cupping therapy-related subdural hematoma: A case report and literature review
por: Xiang, Tangtang, et al.
Publicado: (2022) -
Risk Factors for Atorvastatin as a Monotherapy for Chronic Subdural Hematoma: A Retrospective Multifactor Analysis
por: Zhang, Xinjie, et al.
Publicado: (2021) -
Hematoma-derived exosomes of chronic subdural hematoma promote abnormal angiogenesis and inhibit hematoma absorption through miR-144-5p
por: Gao, Chuang, et al.
Publicado: (2019) -
Atorvastatin Plus Low-Dose Dexamethasone May Be Effective for Leukemia-Related Chronic Subdural Hematoma but Not for Leukemia Encephalopathy: A Report of Three Cases
por: Yuan, Jiangyuan, et al.
Publicado: (2021) -
Atorvastatin combined with dexamethasone promote hematoma absorption in an optimized rat model of chronic subdural hematoma
por: Wang, Dong, et al.
Publicado: (2021)